Search Tag: drug trails
2014 13 May
GlaxoSmithKline has announced that its innovative heart drug darapladib has failed reduce heart attacks or other major cardiac events in patients suffering acute coronary syndrome. This marks a further disappointment for the heart medicine that has previously failed to pass a late-stage trial for patients with well-treated heart disease. ...Read more